Dietary Intake, Biological Status, and Barriers towards Omega-3 Intake in Elite Level (Tier 4), Female Athletes: Pilot Study
Nutrients · 2023
DOI: 10.3390/nu15132821 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2023. Verfasst von Matthew P Hooks und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Biological Sciences, Institute for Global Food Security, Queen's University Belfast, Belfast BT9 5DL, Northern Ireland, UK. Hauptthemen laut MEDLINE: Fatty Acids, Omega-3, Sports Nutritional Physiological Phenomena, Dietary Supplements. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Northern Ireland Department for the Economy, the Department for the Economy Collaborative Award in Science and Technology (DfE CAST).
Abstract (Originalsprache)
Omega-3 polyunsaturated fatty acids (n-3 PUFA) have unique properties which benefit athlete populations. The literature investigating NCAA collegiate, rugby sevens and German endurance athletes indicates suboptimal n-3 PUFA dietary intake and biological status. The aims of this study were: (i) to explore the dietary intakes and FA profiles of elite level, team-based, female athletes and (ii) to understand perceived barriers towards achieving n-3 dietary guidelines. A total of 35 athletes (24.8 ± 4.5 years) completed both a questionnaire and a finger prick test. All the participants reported consuming fish and seafood over the previous six months however only nine athletes consumed ≥ 2 servings of fish per week. Four participants reported using an n-3 supplement. The mean omega-3 index (O3I; including supplementers) was below target levels of >8% (5.19 ± 0.86%). O3I was significantly higher (p < 0.001) in those consuming ≥ 2 servings of fish per week and/or supplements (5.91 ± 0.81%) compared with those who did not (4.82 ± 0.63%). The main barriers reported by those not consuming two servings of fish per week were sensory (n = 11; 42%), cooking skills (n = 10; 38%) and knowledge of n-3 benefits (n = 7; 27%). The current study shows that elite level female athletes present with suboptimal n-3 dietary intake and O3I due to their food preferences, cooking skills and n-3 knowledge.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Biological Sciences, Institute for Global Food Security, Queen's University Belfast, Belfast BT9 5DL, Northern Ireland, UK.
- Sport Ireland Institute of Sport, D15 Y52H Dublin, Ireland.
- Sport and Human Performance Research Centre, University of Limerick, V94 T9PX Limerick, Ireland.
- Department of Physical Education and Sport Sciences, University of Limerick, V94 T9PX Limerick, Ireland.
- Centre for Public Health, Institute for Global Food Security, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast BT9 7BL, Northern Ireland, UK.
- UCD Institute of Food and Health, School of Agriculture and Food Science, University College Dublin, D04 V1W8 Dublin, Ireland.
ORCID-Profile: Jayne V Woodside, Anne P Nugent
Förderung
- Northern Ireland Department for the Economy
- the Department for the Economy Collaborative Award in Science and Technology (DfE CAST)
Zitieren
APA
Hooks, M. P., Madigan, S. M., Woodside, J. V., & Nugent, A. P. (2023). Dietary Intake, Biological Status, and Barriers towards Omega-3 Intake in Elite Level (Tier 4), Female Athletes: Pilot Study. Nutrients. https://doi.org/10.3390/nu15132821
Vancouver
Hooks MP, Madigan SM, Woodside JV, Nugent AP. Dietary Intake, Biological Status, and Barriers towards Omega-3 Intake in Elite Level (Tier 4), Female Athletes: Pilot Study. Nutrients. 2023. doi:10.3390/nu15132821
BibTeX
@article{Hooks2023,
author = {Hooks, Matthew P and Madigan, Sharon M and Woodside, Jayne V and Nugent, Anne P},
title = {Dietary Intake, Biological Status, and Barriers towards Omega-3 Intake in Elite Level (Tier 4), Female Athletes: Pilot Study},
journal = {Nutrients},
year = {2023},
doi = {10.3390/nu15132821}
}
EUVIMED